DRAVP ID Name Sequence Target Organism Pubmed/Patent ID
DRAVPe01993 K6-10 GELGRPVYVLGDPGYYATHCIYATTNDALIFSV HCV 22965230
DRAVPe01994 K6-10-A GELGRPVYVLGDPGYYAT HCV 22965230
DRAVPe01995 CP5-46 GELGRLVYLLDGPGYDPIHCDVVTRGGSHLFNF HCV 22965230
DRAVPe01996 CP5-46-4D5E GELDELVYLLDGPGYDPIHCDVVTRGGSRLFNF HCV 22965230
DRAVPe01997 CP5-46-A GELGRLVYLLDGPGYDPIHCD HCV 22965230
DRAVPe01998 CP5-46A-4D5E GELDELVYLLDGPGYDPIHS HCV 22965230
DRAVPe01999 Ant-CP5-46A-4D5E RQIKINFQNRRMKNKKGELDELVYLLDGPGYDPIHS HCV 22965230
DRAVPe02145 Cyclo(l-Tyr-l-Pro) diketopiperazine YP HCV Not Available
DRAVPe02146 Valinomycin; streptodepsipeptides P11A and SV21 AVVVDAVVVDAVVVDAVVVD HCV 33540548
DRAVPe02271 Labyrinthopeptin A1 SNASVWECCSTGSWVPFTCC DENV,ZIKV,WNV,HCV,CHIKV,KSHV,CMV,HSV-2,HIV-1 31666384,23724015
DRAVPe02272 Labyrinthopeptin A2 SDWSLWECCSTGSLFACC DENV,ZIKV,WNV,HCV,CHIKV,KSHV,CMV,HSV 31666384
DRAVPe02281 Micrococcin P1 SCTTCVCTCSCCTT HCV 27387825
DRAVPe02394 P153 KKKKVVAATYVFF HCV 14694985
DRAVPe02395 P158 KKKKLLLPTLFFF HCV 14694985
DRAVPe02396 P194 DEMEECASHLPYK HCV 14694985
DRAVPe02397 P39 AKLKVVAATYVKKK HCV 14694985
DRAVPe02398 P14 DLEVVAATYV HCV 14694985
DRAVPe02399 P184 KKKKLLLPTLFLF HCV 14694985
DRAVPe02400 P59 KKKKVVALTYVLV HCV 14694985
DRAVPe02401 P160 KKKKLLLPFLVFF HCV 14694985
DRAVPe02402 P192 AKDEMEECASHLPYEA HCV 14694985
DRAVPe02403 P195 FDEMEECSQHLPYA HCV 14694985
DRAVPe02404 P36 KKKKVVAATYKLKA HCV 14694985
DRAVPe02405 P56 KKKKLVAATYVLV HCV 14694985
DRAVPe02406 P171 KKKKVLLAFLFFF HCV 14694985
DRAVPe02407 P193 DEMEEC HCV 14694985
DRAVPe02408 P199 DEVVCC HCV 14694985
DRAVPe02409 P118 KKKKVLLPFLFFV HCV 14694985
DRAVPe02410 P95 KKKKVVAATYVTV HCV 14694985
DRAVPe02411 P85 KKKKVVAAKYVLV HCV 14694985
First 8 9 10 11 12 13 14 Last